Riesgo de Infección por VIH al Picarse con una Aguja

Factores que influyen en el riesgo de transmisión

El riesgo de seroconversión por VIH después de una lesión percutánea con aguja contaminada con sangre infectada por VIH es aproximadamente del 0,36% (3,6 por cada 1.000 exposiciones) 1, 2
La exposición a sangre contaminada con VIH representa el mayor riesgo, siendo las lesiones percutáneas (pinchazos de aguja) uno de los tipos de exposición con mayor riesgo de transmisión 3, 4
El riesgo aumenta cuando hay alta concentración viral en la fuente (paciente con carga viral elevada) 4, 5
El riesgo aumenta cuando la lesión es profunda 6
El riesgo aumenta cuando la aguja ha estado en una vena o arteria del paciente infectado 6
El riesgo disminuye cuando la aguja es de pequeño calibre 5
El riesgo disminuye cuando la aguja ha estado expuesta al ambiente por tiempo prolongado (el virus pierde viabilidad) 5

Comparación con otros virus transmitidos por sangre

El riesgo de transmisión del virus de la hepatitis B (VHB) después de un pinchazo de aguja es significativamente mayor que el del VIH: sin profilaxis, el riesgo puede superar el 30% después de una exposición a sangre positiva para el antígeno e del VHB 7, 2
La vacunación contra la hepatitis B reduce este riesgo prácticamente a cero 7

Manejo de la exposición por pinchazo de aguja

Medidas inmediatas: lavar el sitio de la lesión inmediatamente con agua y jabón 6
Evaluación del riesgo: determinar el estado serológico de la fuente (si es posible) 4, 5
Profilaxis postexposición (PEP): debe iniciarse lo antes posible, idealmente dentro de la primera hora después de la exposición, y consiste en una combinación de medicamentos antirretrovirales durante 28 días 3, 4

Prevención

Implementar prácticas seguras de manejo de objetos punzocortantes: desechar adecuadamente los objetos punzocortantes en contenedores apropiados 1
Vacunación contra la hepatitis B para todo el personal sanitario 7, 2

Consideraciones especiales

Las agujas desechadas en lugares públicos generalmente representan un riesgo bajo: solo el 3,8% de las jeringas usadas en pacientes con VIH tienen ARN viral detectable 5
Menos del 1% de los virus permanecen viables después de una semana de almacenamiento a temperatura ambiente elevada 5
Se debe establecer un protocolo claro y accesible para el manejo de exposiciones ocupacionales en todos los centros sanitarios 6

Risk of HIV Transmission from Insulin Needle Stick Injuries

Risk Factors Affecting HIV Transmission

The Centers for Disease Control and Prevention recommends that hollow-bore needles that have been placed in a vein or artery and visible blood on the device increase the risk of HIV transmission 8

Comparative Risk Assessment

There are no confirmed reports of HIV transmission during sporting activities, suggesting extremely low risk in non-healthcare settings, as reported by the British Journal of Sports Medicine 9
Most insulin needle use occurs in home settings by persons whose HIV status is unknown, making the absolute risk difficult to quantify, according to the Mayo Clinic Proceedings 10

Prevention Strategies

The Mayo Clinic recommends using safety-engineered devices, 4-5mm pen needles or 6mm insulin syringe needles without a skinfold when possible, and avoiding recapping needles to protect against needlestick injuries 10
Proper sharps disposal, including using dedicated sharps containers and following local safety and disposal regulations, is recommended by the Mayo Clinic Proceedings 10

Management of Potential Exposure

The Centers for Disease Control and Prevention recommends completing the full 4-week post-exposure prophylaxis (PEP) regimen if initiated after a needlestick injury with a potentially HIV-contaminated insulin needle 8

HIV Post-Exposure Prophylaxis Guidelines

Immediate Actions and Risk Assessment

The Centers for Disease Control and Prevention (CDC) recommends starting post-exposure prophylaxis (PEP) immediately if presentation occurs within 72 hours of the needle prick injury, ideally within 24 hours, using a 28-day course of combination antiretroviral therapy, even when the source person's HIV status is unknown 11
The sooner PEP is initiated, the more effective it is at preventing HIV transmission, with effectiveness decreasing significantly after 72 hours 12, 11
Presenting to a healthcare facility within 72 hours (ideally within 24 hours) is crucial as PEP effectiveness decreases significantly after this window 13, 11
The risk of HIV transmission from a percutaneous needle injury with HIV-infected blood is approximately 0.3-0.36% (3-4 per 1,000 exposures), but needles discarded in public places have an even lower risk 12
Viable HIV virus is recovered from only 8% of needles after 21 days at room temperature, and less than 1% remain viable after one week at higher temperatures 12
Despite low risk, no HIV infections from discarded needles have been documented in medical literature 12
Large-bore needles increase the risk of HIV transmission 12

PEP Initiation and Regimen

The CDC recommends evaluating PEP on a case-by-case basis when the source HIV status is unknown, but given the consequences of HIV infection versus the manageable risks of PEP medications, initiation is reasonable for substantial exposures 11
Start PEP if the exposure occurred within 72 hours (preferably within 24 hours) 11
Do not wait for HIV test results before starting the first dose 11
Consider starting PEP while attempting to determine if the source could be from a high HIV prevalence population (injection drug users, commercial sex workers) 13, 14
The preferred regimens for adults and adolescents include Bictegravir/emtricitabine/tenofovir alafenamide (single tablet once daily) or Dolutegravir plus (tenofovir alafenamide or tenofovir disoproxil fumarate) plus (emtricitabine or lamivudine) 11
Complete the full 28-day course of PEP 12, 11

Testing Protocol and Follow-Up

Rapid HIV test or laboratory-based antigen/antibody combination HIV test should be performed before starting PEP 11
Do not delay the first PEP dose while waiting for laboratory results 11
Follow-up testing schedule includes 24-hour follow-up, 4-6 weeks post-exposure HIV testing, and 12 weeks post-exposure final HIV testing 11

Critical Pitfalls to Avoid

Do not delay PEP initiation beyond 72 hours, as effectiveness drops dramatically 13, 11
Do not stop PEP prematurely, as the full 28-day course is essential 12, 11
Do not use PEP as a substitute for ongoing prevention if you have frequent exposures; instead, consider pre-exposure prophylaxis (PrEP) 13, 11
Do not attempt to test the needle itself for HIV, as this is not reliable or recommended 15

Medication Side Effects Management

Common side effects of PEP medications include nausea and gastrointestinal symptoms 14
Anti-nausea medications (antiemetics) or anti-diarrheal agents can improve adherence 14
Report any severe symptoms immediately to your healthcare provider 14

HIV Transmission Risk from Percutaneous Needlestick Injuries Through Gloves

Baseline Transmission Risk

The Centers for Disease Control and Prevention (CDC) estimate that the average risk of HIV infection after a percutaneous exposure to HIV‑infected blood is 0.3 % (95 % CI 0.2 %–0.5 %), corresponding to roughly 3 infections per 1,000 needlestick exposures. 16

Effect of Needle Type and Glove Penetration

The CDC notes that hollow‑bore needles markedly increase transmission risk compared with solid needles because they convey larger volumes of blood into the wound. 16
When a hollow‑bore needle penetrates nitrile gloves, the glove may slightly reduce the inoculum size by wiping some blood off the needle surface during passage. 16
Despite glove penetration, hollow‑bore needles retain blood within their lumen, so the protective effect of the glove is limited and does not substantially lower the risk relative to exposures with solid needles. 16

Clinical Implications

Because the CDC’s baseline 0.3 % risk estimate already incorporates many exposures performed while wearing gloves, clinicians should not assume that glove penetration meaningfully reduces the probability of HIV acquisition after a hollow‑bore needlestick injury. 16
The CDC emphasizes that health‑care workers should not rely on glove protection when a hollow‑bore needle punctures the glove, as the retained blood in the needle lumen maintains a transmission risk comparable to ungloved exposures. 17